How are NOACs doing in the real world?

Professor Craig Coleman is a leading expert in drug evaluation, with over 180 publications to his name. He is the lead author of a just published study, REVISIT-US, which looks at rates of ischaemic stroke and intracranial haemorrhage in almost 30,000 people who were prescribed rivaroxaban, apixaban or warfarin for non-valvular atrial fibrillation.

Prof Coleman, who was in Australia this month to